Symbols

ULBI

Ultralife·NASDAQ

--(--)

ULBI fundamentals

ULBI Q4 2025 Earnings

Ultralife (ULBI) released its earnings on Mar 10, 2026: revenue was 48.48M (YoY +10.56%), missed estimates; EPS was -0.45 (YoY -4600.00%), missed estimates.

Revenue / YoY

48.48M

+10.56%

EPS / YoY

-0.45

-4600.00%

Report date

Mar 10, 2026

ULBI Earnings Call Summary for Q4,2025

Revenue Growth: Q4 2025 revenue up 10.6% YoY to $48.5M, full year +16.2% from new products
Margin Expansion: Adjusted EBITDA of 11.7%, up from 8.9%, with Battery & Energy gross margin improving 170bps
Backlog Strength: $110M backlog (58% of TTM sales), $6M from 2025 new products
2026 Priorities: Communications Systems profitability, Battery margin improvement, brand consolidation
Medical Opportunity: 6+ figure annual revenue from new medical battery orders
Risks: Customer qualification delays, program launch timing

Earnings

EPS

Revenue

Revenue & Expenses

ULBI has released its 2025 Q4 earnings report, with revenue of 48.48M, reflecting a YoY change of 10.56%, and net profit of -7.45M, showing a YoY change of -3298.71%. The Sankey diagram below clearly presents ULBI's revenue sources and cost distribution.

Key Indicators

Ultralife (ULBI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Ultralife (ULBI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Ultralife (ULBI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Ultralife (ULBI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown